Our Biologics US Congress featuring the Proteins & Antibodies and ADC Discovery & Development programs, sets out to answer this question - over 6 tracks, uncover the next generation of biologics research, from novel engineering strategies to enhance antibody function & AI-driven antibody design to optimizing ADCs and utilizing these beyond just oncology. This revamped program will be packed with interactivity, networking opportunities and exclusive talks to equip you with the knowledge and connections needed to inform your pipeline and ensure the success of your R&D.